Evidence map›Paper›PMID 35133700›Full record

ArticleDermatologic therapy2022

Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasis.

Oyku Durmus, Neslihan Akdogan, Omer Karadag, Ozay Gokoz

Abstract readLetter
In one paragraph

Article in Dermatologic therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.Clinical, cosmetic and investigational dermatology · 2022
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Oyku DurmusSchool of Medicine, Department of Dermatology and Venereology, Hacettepe University, Ankara, Turkey.ORCID 0000-0003-1793-2122
Neslihan AkdoganSchool of Medicine, Department of Dermatology and Venereology, Hacettepe University, Ankara, Turkey.ORCID 0000-0002-1137-5399
Omer KaradagSchool of Medicine, Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey.ORCID 0000-0002-3443-3117
Ozay GokozSchool of Medicine, Department of Pathology, Hacettepe University, Ankara, Turkey.ORCID 0000-0001-9537-1127

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Dermatitis, ExfoliativePsoriasisBNT162 VaccineCOVID-19 VaccinesHumansmRNA VaccinesRNA, MessengerVaccines, SyntheticBNT162 VaccineCOVID-19 VaccinesmRNA VaccinesRNA, MessengerVaccines, Synthetic

Identifiers

PMID35133700
PMCPMC9111652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.